- Supported by
Have You Registered?
APASL STC Yokohama Pre-Registration is available
until Friday April 27, 2018!
Pre–registration is available at
Please save JPY 5,000!
APASL STC Yokohama Registration Fee List:
|Before Feb. 28 (Wed) 2018
|From Mar. 1 (Thu) 2018
|Trainee / Resident||JPY10,000||JPY15,000||JPY20,000|
- Registration will be confirmed after receiving full payment. Those who do not receive a confirmation notice before the conference are requested to contact the congress secretariat.
- Date of payment is decisive for the registration fee. Even if the registration form is received before the early bird deadline, it will not be considered as early bird registration if the payment has not been received before the deadline.
- Registration Fees are included Tax.
Invitation to APASL STC Yokohama (off the Coast of Kanagawa)
APASL STC Yokohama (off the Coast of Kanagawa)
Kaminari, the God of Thunder: Hey Kaze, did you hear? The theme of the next conference is “HCC: Strategy in the New Era”.
Kaze, the God of Wind: Kaminari, that’s what’s in the wind. Doctors in the liver field have blown away hepatitis C and can control hepatitis B too.
Kaminari: You got that right. But one thing’s got me worried. They say obesity-related nonalcoholic fatty liver is increasing the number of cancer patients. That’s a thunderous worry, but innovation is coming lightning fast in surgical methods, image-guided ablation, vascular intervention, and even pharmacotherapy.
Kaze: Those all sound good, but how tasty are they, really?
Kaminari: You old fool! Those aren’t foods?
Kaze: Well, they all sound expensive. In a graying society and with medical fees going sky high, a storm is brewing for cost effectiveness.
Kaminari: That may be the eye of the storm. The APASL STC Yokohama will flash light on various topics related to hepatocellular carcinoma. I’m done rumbling here, let’s blow.
Kaze: Wait, Kaminari!
APASL STC Yokohamaのご案内（風神 雷神編）
APASL STC 神奈川沖 風神雷神図
雷「ようよう風さん、きいたかい、今度の学会は 「HCC: Strategy in the new era」がメイン テーマらしいぜ」
風「雷さん、おいらも知ってるぞぅ。なんでも 肝細胞癌の分野じゃあ、C 型肝炎ウイルスが めっぽう追っ払えるようになって、 B 型肝炎 ウイルスも制御できるようになってんだってよぅ。」
雷「風さん、おめえすげーこと知ってるじゃねえか。 しかしなぁ、かたっぽじゃ肥満に伴う脂肪肝 からの発癌患者の増加がしんぺえされてるって 言うじゃねーか。外科手術やらラジオ波治療 やらのアブレーション、 肝動脈塞栓術、薬物 療法の分野でもいろんなイノベーションが 起こってるらしいな。」
風「雷さん、何言ってるかわかんねえな。 あぶ、、、? いの、、、? うめえのか、それは。」
風「でも雷さん、高齢化社会や医療費増大抑止の コストエフェクティブネスの追及も必要に なってるんだってよ。」
雷「おめえ、そんなのどこで覚えてきやがった！ するってえと APASL STC Yokohama じゃあ、 そういった肝細胞癌の諸問題を集中的に検討 するわけだな。こりゃあ、こうしちゃいられねえ、 行くぜ、風さん！」
On behalf of the Organizing Committee, it gives us great pleasure to invite you to Asian Pacific Association for the Study of the Liver Single Topic Conference (APASL STC), which will be held on May 11-13, 2018 in Yokohama, Japan. We are delighted to welcome you to the beautiful, international city.
Under the theme of “HCC: Strategy in the New Era”, the conference program will present high-quality content based on up-to-date information and cutting edge lectures by eminent researchers, in order to reconfirm the achievement of better basic and clinical practice in the field of hepatocellular carcinoma (HCC).
The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers on significant developments on the theme of “HCC: Strategy in the New Era”. The program will also provide the latest information and fresh ideas for hepatologists.
The conference encourages the submission of abstracts on research for oral and poster presentations through the conference website: http://www.apaslstc-hcc2018.org/. We would appreciate your submission and anticipate a large number of entries, which will stimulate active discussions. We would accept all categories of abstracts on HCC, including case reports.
Approximately 1000 delegates of experts from all over the world are expected to attend this conference. We are sure that this will provide an excellent opportunity for those of us in the Asian Pacific region to share the latest views, values, experience and practice, and greatly contribute to this field.
We look forward to welcoming you in Yokohama.
With warmest regards,
Shuichiro Shiina, MD, PhD
President, APASL STC 2018 on HCC